We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-11.15%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$660M
AUM Growth
-$90.2M
Cap. Flow
+$191K
Cap. Flow %
0.03%
Top 10 Hldgs %
44.67%
Holding
1,273
New
125
Increased
484
Reduced
238
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 3.26%
2 Healthcare 2.67%
3 Financials 1.79%
4 Consumer Discretionary 1.47%
5 Industrials 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADI icon
601
Analog Devices
ADI
$185B
$14K ﹤0.01%
97
DLB icon
602
Dolby
DLB
$5.59B
$14K ﹤0.01%
+190
New +$14.4K
EBAY icon
603
eBay
EBAY
$47.6B
$14K ﹤0.01%
339
EIX icon
604
Edison International
EIX
$27.2B
$14K ﹤0.01%
220
+2
+0.9% +$136
HYG icon
605
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$14K ﹤0.01%
190
IEX icon
606
IDEX
IEX
$17.2B
$14K ﹤0.01%
78
-28
-26% -$5.28K
LII icon
607
Lennox International
LII
$15.4B
$14K ﹤0.01%
+69
New +$15.1K
RDIV icon
608
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.4B
$14K ﹤0.01%
332
+2
+0.6% +$86
ROL icon
609
Rollins
ROL
$18.2B
$14K ﹤0.01%
+405
New +$13.9K
SCHW
610
Charles Schwab
SCHW
$184B
$14K ﹤0.01%
225
+214
+1,945% +$14.8K
BCE icon
611
BCE
BCE
$20.3B
$13K ﹤0.01%
260
+3
+1% +$161
BNY
612
Bank of New York Mellon
BNY
$106B
$13K ﹤0.01%
311
CGC
613
Canopy Growth
CGC
$404M
$13K ﹤0.01%
468
CRON
614
Cronos Group
CRON
$1.06B
$13K ﹤0.01%
4,560
CVS icon
615
CVS Health
CVS
$133B
$13K ﹤0.01%
138
+25
+22% +$2.44K
GMED icon
616
Globus Medical
GMED
$11.1B
$13K ﹤0.01%
235
+201
+591% +$13.2K
OGI
617
Organigram Holdings
OGI
$136M
$13K ﹤0.01%
3,505
SLYG icon
618
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.26B
$13K ﹤0.01%
185
STZ icon
619
Constellation Brands
STZ
$22.4B
$13K ﹤0.01%
57
VRTX icon
620
Vertex Pharmaceuticals
VRTX
$119B
$13K ﹤0.01%
45
+23
+105% +$6.16K
AQN icon
621
Algonquin Power & Utilities
AQN
$4.42B
$12K ﹤0.01%
902
+518
+135% +$7.5K
CI icon
622
Cigna
CI
$74.5B
$12K ﹤0.01%
45
+22
+96% +$5.67K
DOV icon
623
Dover
DOV
$27.7B
$12K ﹤0.01%
103
EEM icon
624
iShares MSCI Emerging Markets ETF
EEM
$29.7B
$12K ﹤0.01%
297
+2
+0.7% +$84
EOG icon
625
EOG Resources
EOG
$77.6B
$12K ﹤0.01%
108
+41
+61% +$5.09K

Similar funds

Arax Advisory Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Arax Advisory Partners held 1,273 positions worth $660M, down 12% from $751M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Arax Advisory Partners's Q2 2022 filing shows 125 new, 484 increased, 238 reduced and 119 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 797,943 shares worth $73M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $36.9M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

  • Arax Advisory Partners's largest Q2 2022 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 797,943 shares worth $73M.
  • Arax Advisory Partners added most to iShares Russell 2000 Value ETF in Q2 2022, an estimated $30.3M increase.
  • Arax Advisory Partners's biggest Q2 2022 reduction was iShares S&P Mid-Cap 400 Value ETF, cutting an estimated $34.6M.
  • Arax Advisory Partners fully exited iShares S&P Small-Cap 600 Value ETF in Q2 2022, selling an estimated $36.9M.
  • Arax Advisory Partners's ten largest holdings make up 45% of its $660M portfolio in Q2 2022.
  • Arax Advisory Partners opened 125 new positions and closed 119 in Q2 2022.
  • Arax Advisory Partners's portfolio value fell 12% quarter-over-quarter to $660M.

Based on Arax Advisory Partners's 13F filing for Q2 2022, filed 22 Aug 2022.